The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks rise past two-week highs on earnings optimism

Thu, 14th Oct 2021 09:57

* STOXX 600 on course for weekly gains

* Chip stocks boosted by TSMC results

* Publicis up on outlook hike
(New throughout, updates prices, market activity and comments
to close)

By Sruthi Shankar and Susan Mathew

Oct 14 (Reuters) - European stocks rose on Thursday, hitting
the highest in more than two weeks as investors bet a steady
economic recovery from the pandemic-induced slump will support
corporate earnings despite signs of elevated inflation.

Mining shares jumped 3.3%, their biggest daily gain
in three months, technology stocks rallied again and the
pan-European STOXX 600 index rose 1.2%.

European chipmakers, including ASML, Infineon
and BE Semiconductor, were among the top
gainers in the tech sector after Taiwan chip giant TSMC
posted a 13.8% jump in third-quarter profit due to
booming demand for semiconductors.

China's factory gate inflation rose in September to a record
high on soaring commodity prices. Many still hope
inflation will be transitory, but supply chain disruptions, a
global energy crisis and labour shortages have fuelled concerns
that central banks could raise interest rates sooner,
accelerating plans for a gradual exit from the pandemic-era
stimulus.

"Equity markets appear to have shaken off their caution of
recent weeks," said Chris Beauchamp, chief market analyst at IG.
Upbeat results from Wall Street banks, big European names
such as LVMH and SAP, as well as TSMC reinforced the view of a
global economy still moving in the right direction, albeit at a
slower place, he said.

"Having dropped back in an orderly fashion into earnings
season, it seems stock markets have now reached a level at which
investors are once again happy about buying the dip..."

Optimism around the earnings has seen the STOXX 600 narrow
the gap to its all-time highs to 2%.

Analysts expect third-quarter profit for STOXX 600 companies
to climb 46.7% from a year ago, according to Refinitiv IBES
data, with energy companies enjoying the biggest revisions.

Among individual stocks, French advertising group Publicis
gained 2.7% after it raised its outlook for 2021 as a
global shift towards digital media and e-commence helped
third-quarter organic growth exceed market expectations. British
rival WPP rose 0.5%.

Danish food ingredients maker Chr Hansen dropped
6.7% after fourth-quarter profit cam in below estimates.

SAP gained 2.9%, the biggest boost to the tech
sector, after the German software firm's shares jumped nearly 4%
in the previous session following a strong quarterly report.

The biggest drag on the STOXX 600 was AstraZeneca,
down 0.5%. Europe's drug regulator said it had started a
real-time review of the drugmaker's antibody-based COVID-19
therapy.

(Reporting by Sruthi Shankar in Bengaluru; Editing by Sriraj
Kalluvila, Amy Caren Daniel and David Gregorio)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.